Atlas Trials

A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology

Clinical trial NCT01106781 · COMPLETED

Trial details

NCT number
NCT01106781
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Non-Small Cell Lung Cancer
Start date
2010-08-01
Primary completion
2014-01-01
Enrollment
591

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.